243 related articles for article (PubMed ID: 17921321)
1. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.
Bone DB; Hammond JR
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3325-32. PubMed ID: 17921321
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells.
Archer RG; Pitelka V; Hammond JR
Br J Pharmacol; 2004 Sep; 143(1):202-14. PubMed ID: 15289294
[TBL] [Abstract][Full Text] [Related]
3. A purine-selective nucleobase/nucleoside transporter in PK15NTD cells.
Hoque KM; Chen L; Leung GP; Tse CM
Am J Physiol Regul Integr Comp Physiol; 2008 Jun; 294(6):R1988-95. PubMed ID: 18417653
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress modulates nucleobase transport in microvascular endothelial cells.
Bone DB; Antic M; Vilas G; Hammond JR
Microvasc Res; 2014 Sep; 95():68-75. PubMed ID: 24976360
[TBL] [Abstract][Full Text] [Related]
5. Hypoxanthine uptake and release by equilibrative nucleoside transporter 2 (ENT2) of rat microvascular endothelial cells.
Robillard KR; Bone DB; Hammond JR
Microvasc Res; 2008 Apr; 75(3):351-7. PubMed ID: 18048066
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside/nucleobase transport and metabolism by microvascular endothelial cells isolated from ENT1-/- mice.
Bone DB; Choi DS; Coe IR; Hammond JR
Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H847-56. PubMed ID: 20543083
[TBL] [Abstract][Full Text] [Related]
7. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
Ward JL; Sherali A; Mo ZP; Tse CM
J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
[TBL] [Abstract][Full Text] [Related]
8. Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).
Playa H; Lewis TA; Ting A; Suh BC; Muñoz B; Matuza R; Passer BJ; Schreiber SL; Buolamwini JK
Bioorg Med Chem Lett; 2014 Dec; 24(24):5801-5804. PubMed ID: 25454272
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
[TBL] [Abstract][Full Text] [Related]
10. Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.
Stolk M; Cooper E; Vilk G; Litchfield DW; Hammond JR
Biochem J; 2005 Mar; 386(Pt 2):281-9. PubMed ID: 15500446
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1.
Hammond JR; Stolk M; Archer RG; McConnell K
Eur J Pharmacol; 2004 Apr; 491(1):9-19. PubMed ID: 15102528
[TBL] [Abstract][Full Text] [Related]
12. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
Hammond JR
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
[TBL] [Abstract][Full Text] [Related]
13. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
14. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
[TBL] [Abstract][Full Text] [Related]
15. Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation.
Yao SY; Ng AM; Vickers MF; Sundaram M; Cass CE; Baldwin SA; Young JD
J Biol Chem; 2002 Jul; 277(28):24938-48. PubMed ID: 12006583
[TBL] [Abstract][Full Text] [Related]
16. Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
Paproski RJ; Visser F; Zhang J; Tackaberry T; Damaraju V; Baldwin SA; Young JD; Cass CE
Biochem J; 2008 Sep; 414(2):291-300. PubMed ID: 18462193
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
18. Effect of thiazolidinediones on equilibrative nucleoside transporter-1 in human aortic smooth muscle cells.
Leung GP; Man RY; Tse CM
Biochem Pharmacol; 2005 Aug; 70(3):355-62. PubMed ID: 15963471
[TBL] [Abstract][Full Text] [Related]
19. Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).
Yao SY; Ng AM; Cass CE; Baldwin SA; Young JD
J Biol Chem; 2011 Sep; 286(37):32552-62. PubMed ID: 21795683
[TBL] [Abstract][Full Text] [Related]
20. Hypoxanthine uptake by skeletal muscle microvascular endothelial cells from equilibrative nucleoside transporter 1 (ENT1)-null mice: effect of oxidative stress.
Bone DB; Antic M; Quinonez D; Hammond JR
Microvasc Res; 2015 Mar; 98():16-22. PubMed ID: 25448155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
